SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-376648
Filing Date
2015-11-13
Accepted
2015-11-13 11:03:24
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d21464d10q.htm 10-Q 466374
2 EX-10.21 d21464dex1021.htm EX-10.21 11025
3 EX-31.1 d21464dex311.htm EX-31.1 8927
4 EX-31.2 d21464dex312.htm EX-31.2 8924
5 EX-32.1 d21464dex321.htm EX-32.1 5421
  Complete submission text file 0001193125-15-376648.txt   2114469

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aldx-20150930.xml EX-101.INS 259779
7 XBRL TAXONOMY EXTENSION SCHEMA aldx-20150930.xsd EX-101.SCH 25747
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20150930_cal.xml EX-101.CAL 36092
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20150930_def.xml EX-101.DEF 75513
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20150930_lab.xml EX-101.LAB 221164
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20150930_pre.xml EX-101.PRE 149155
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 151227578
SIC: 2834 Pharmaceutical Preparations